WO2005041908A1 - Perfume delivery systems based on inorganic nano particles - Google Patents

Perfume delivery systems based on inorganic nano particles Download PDF

Info

Publication number
WO2005041908A1
WO2005041908A1 PCT/IB2004/003539 IB2004003539W WO2005041908A1 WO 2005041908 A1 WO2005041908 A1 WO 2005041908A1 IB 2004003539 W IB2004003539 W IB 2004003539W WO 2005041908 A1 WO2005041908 A1 WO 2005041908A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
delivery system
formula
perfuming
ingredient
Prior art date
Application number
PCT/IB2004/003539
Other languages
French (fr)
Inventor
Walter Paget
Otto GRÄTHER
Ralph Nonninger
Christian Goebbert
Rainer Wittmer
Original Assignee
Firmenich Sa
Itn Nanovation Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Firmenich Sa, Itn Nanovation Gmbh filed Critical Firmenich Sa
Priority to EP04769749A priority Critical patent/EP1687069A1/en
Priority to JP2006537471A priority patent/JP2007511625A/en
Publication of WO2005041908A1 publication Critical patent/WO2005041908A1/en
Priority to US11/416,493 priority patent/US20060263898A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585Organosilicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50Perfumes
    • C11D3/502Protected perfumes
    • C11D3/507Compounds releasing perfumes by thermal or chemical activation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41Particular ingredients further characterized by their size
    • A61K2800/413Nanosized, i.e. having sizes below 100 nm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances

Definitions

  • the present invention relates to the field of the chemical delivery systems, and more precisely to the perfumery and pharmaceutical fields.
  • the invention concerns a delivery system which comprises a nano particle moiety and a releasing moiety.
  • the invention's delivery system is capable of liberating in a controlled manner an active compound belonging to the ⁇ , ⁇ -unsaturated etone, aldehyde or carboxylic ester families.
  • the present invention concerns also the use of said delivery system as perfuming ingredient as well as the perfuming compositions or perfumed articles comprising the invention's delivery system.
  • Other objects of the invention are pharmaceutical compositions or drugs comprising the invention's delivery system.
  • Inorganic materials have been described in the prior art as useful carriers for active ingredients.
  • silica has been widely disclosed as carrier for perfumes or perfume precursors, also referred to as "pro-perfumes".
  • WO 01/83398 discloses a delivery system consisting of porous silica carrying pro-perfumes.
  • the pro-perfumes are either adsorbed in silica pores, or chemically bonded after chemical modification of the pores' surface.
  • the size of the silica particles is not specifically cited in this document, it can be deduced from the description of silica pores that the systems are certainly on a micron scale. As a consequence, the particles are not able to form solid suspensions in a liquid.
  • the disclosed delivery systems when used in application such as in a cleaning or detergent product, due to their size, the disclosed delivery systems present the risk of leaving residues on the treated surfaces, for instance a fabric in the case of a detergent. Finally, these systems also present stability problems, as the pro-perfumes adsorbed within the pores of the inorganic material are susceptible to diffuse in the environment during a prolonged storage. To the best of our knowledge, systems based on other inorganic materials do not solve these problems.
  • the present invention now provides a solution to the above-mentioned problems, thanks to a delivery system which is on a nanosize scale and which comprises an inorganic nano particle moiety covalently bonded to at least one organic releasing moiety.
  • the nano-size of the particles allows using the delivery systems of the invention in the form of solid dispersions in a liquid.
  • Systems on a nanosize scale have been described in the prior art. i particular WO 02/50230 or yet DE 19841147 disclose "nano" systems. However the latter documents are based on the use of organic carriers, i.e. polymers or oligomers dissolved in one phase. These carriers are therefore dispersed in water so as to form nanoemulsions.
  • a nanoemulsion is a liquid system which is, by virtue of its nature, susceptible of being destabilized easily when used in an application, for instance in the presence of a surfactant system.
  • coalescence, and ripening may be cited as examples of such destabilization phenomena and they consequently alter the nanometric distribution of the emulsion system.
  • the present invention provides a solution to said problem with the use of an inorganic carrier such as SiO 2 , which is modified in its surface so as to be covalently bonded with organic moiety such as pro-perfumes.
  • an inorganic carrier such as SiO 2
  • organic moiety such as pro-perfumes.
  • the inorganic nature of the carrier allows to prepare solid dispersions which are much more stable than emulsion-type systems and which present, as a consequence, a stable nanometric distribution.
  • a delivery system comprising a nano particle moiety covalently bonded to at least one ⁇ -oxy, ⁇ -thio or ⁇ -amino carbonyl moiety is a valuable perfuming or therapeutical ingredient capable of liberating in a controlled manner an active compound.
  • active compound we mean here a compound capable of bringing a benefit into the surrounding environment into which is it released by the invention's delivery system. Said benefit could be related to an olfactif effect, e.g. an odor, or to a therapeutical effect. Therefore, said "active compound” can be an active perfuming ingredient or an active therapeutical ingredient.
  • said active compound is an active ⁇ , ⁇ -unsaturated ketone, aldehyde or carboxylic ester, preferably an active ⁇ , ⁇ -unsarurated ketone or aldehyde.
  • said active compound is a perfuming ingredient.
  • perfuming ingredient it is meant here a compound, which is of current use in the perfumery industry, i.e. a compound which is used as active ingredient in perfuming preparations or compositions in order to impart a hedonic effect.
  • said active compound is a therapeutical ingredient.
  • therapeutic ingredient it is meant here a compound, which is of current use in the pharmaceutical industry, i.e. a compound which is incorporated into a pharmaceutical preparation, as active ingredient, to treat a disease or pain.
  • an ingredient, to be considered as being a therapeutical one must be recognized by a person skilled in the art of pharmacy as being able to provide a positive effect to the health of a patient.
  • the delivery system of the invention comprises a nano particle moiety.
  • Said moiety constitutes the inorganic part of the invention's delivery system and is a mono or multi radical, depending on the number of releasing moieties bonded to it.
  • Said moiety is derived from an inorganic nano particle.
  • nano particle we mean here a particle having a mean particle size comprised between 2 run and 500 nm, measured with the Microtrac Ultrafine Particle Analyser (UP A). Preferably the size is comprised between 15 nm and 50 nm.
  • the inorganic nario particle, from which the nano particle moiety can be derived can be made from inorganic materials such as amorphous or crystalline metal oxides, hydroxides, oxo-hydroxides or mixtures thereof.
  • Suitable examples of such metals are elements of the I, II, HI or IV main group, e.g. Al, Si, hi, Sn, Ca, Ba or Sr, or yet the transition elements, e.g. Ti, Zr, Fe, Ag or Zn.
  • Particularly suitable nano particle moieties are those derived from a nano particle made from oxides or hydroxides of Ti, Si, Zr, Al, Fe or mixtures thereof.
  • the nano particles moieties made from oxides or hydroxides of Si are especially suitable for the purpose of the invention, whereas for a pharmaceutical application, it is preferable to use Si or Fe based nano particle moieties.
  • the nano particle, from which the nano particle moiety is derived has X-ray diffraction characteristics, measured with a Siemens D500 X-ray diffractometer with Cu-K ⁇ radiation and scintillation counter, in the 2 ⁇ range between 15° and 85°. Said 2 ⁇ range indicates that the spherical nano particles made of silica are mainly amorphous. Density can also be used to characterise the nano particles.
  • a nano particle made from silica may have a density comprised between 2 and 2.4 g/cm 3 , preferably between 2.2 and 2.3 g/cm 3
  • a nano particle made from titanium oxide may have a density ranging from 3.8 to 4.3 g/cm 3 , preferably from 3.8 to 3.9 g/cm 3
  • the nano particle made from alumina may have a density ranging from 3.8 to 4.2 g/cm 3
  • a nano particle made from iron oxide may have a density comprised between 5.0 and 6.0 g/cm 3 .
  • the specific surface area as measured by He-gas pycnometer AccuPyc 1330 from Micromeritics, is comprised between approximately 20 and 200 m 2 /g, preferably between 40 and 60 m 2 /g.
  • the surface charge of the particle is negative and the Zeta potential, measured with Malvern Zetasizer 2000, does not reveal no-charge point in the range from pH 2 to pH 11.
  • This inorganic nano particle moiety is covalently bonded by means of n (Si-O)- bondsto at least one releasing moiety of formula (P-X) m -R-Si(OR 5 ) 3-n (O ⁇ ) n (I) wherein the arrow indicates the location of the bond between said releasing moiety and the nano particle moiety, n representing an integer comprised between 1 to 3, and wherein a) P represents a group derived from a active perfume ingredient and which is represented by formula (H)
  • R 1 represents a hydrogen atom, a to Ce alkoxyl radical or a d to C 15 linear or branched or cyclic alkyl, alkenyl or alkadienyl group, optionally substituted by one to four Ci to C 4 alkyl groups
  • R 2 , R 3 and R 4 represent a hydrogen atom, a C 6-8 aromatic ring or a Ci to C1 5 linear, cyclic or branched alkyl, alkenyl or alkadienyl group, optionally substituted by one to four Ci to C 4 alkyl groups; two, or three, of said R 1 to R 4 being optionally bonded together to form a saturated or unsaturated ring having 6 to 20 carbon atoms and including the carbon atom to which said R 1 , R 2 , R 3 or R 4 groups are bonded, this ring being optionally substituted by one to four Ci to C linear or branched alkyl or alken
  • R 10 represents a hydrogen atom or a hydroxy group
  • R 11 represents a hydrogen atom or a C ⁇ CH, CH 3 CO or HOCH 2 CO group
  • X represents a functional group selected from the group consisting of the formulae i) to vi): ⁇ ) iii)
  • R represents a linear, branched or cyclic multivalent group (with a m+1 valence) derived from a -C 15 alkyl or alkylaryl group, said group optionally containing one or two functional groups selected from the group consisting of oxygen and sulfur atoms, CO, COO, CONR 6 , COS and N ⁇ R 6 ) a , R 6 being defined as above and a representing 0 or 1, d) R 5 represents a linear or branched Ci to C alkyl group; and e) m represents 1, 2 or 3.
  • P in formula (I) is a group derived from an active perfuming ⁇ , ⁇ -unsaturated ketone, aldehyde or carboxyhc ester having from 8 to 20 carbon atoms, or more preferably between 11 and 15 carbon atoms.
  • P is a group derived from a therapeutical ⁇ , ⁇ -unsaturated steroid having from 19 to 26 carbon atoms, or more preferably between 19 and 21 carbon atoms.
  • the invention's delivery system will preferably comprise a releasing moiety (I) wherein P is a group selected from the group consisting of the formulae (P-l) to (P-12)
  • P is a group of formula (P-13) or (P-14) (P-13) (P-14)
  • the X group is preferably selected from the group consisting of formulae i), ii) and iii), as defined above, R 6 representing a hydrogen atom or a methyl or ethyl group. More preferably, X represents a group of formula ii) or iii), as defined above, R 6 representing a hydrogen atom or a methyl or ethyl group.
  • R represents a linear, branched or cyclic divalent or trivalent group derived from a C 2 -C 9 alkyl group, said group optionally containing one or two functional groups selected from the group consisting of oxygen and sulfur atoms, COO, CONR 6 , and N(R 6 ) a , R 6 being defined as above and a representing 0 or 1, R 5 represents a methyl, ethyl or propyl group, and m is 1 or 2.
  • R represents a linear, branched or cyclic divalent group derived from a C 2 -C 6 alkyl group optionally containing one functional groups selected from the group consisting of oxygen and sulfur atoms, COO, and N(R 6 ) a , R 6 being defined as above and a being 1, R 5 represents a methyl, ethyl or propyl group, and m is 1.
  • the invention's delivery system is one wherein P is a radical of formula (P-l) or (P-7), as defined above; X represents a functional group of formula ii) or iii), R 6 representing a hydrogen atom; R represents a linear or branched divalent group derived from a C 2 -C 6 alkyl group; R 5 represents a methyl, ethyl or propyl group; and m is 1, and n represents 1, 2 or 3.
  • a further particularly appreciated delivery system is one wherein P is a group of formula (P-2) as defined above, X represents a functional group of formula ii), R represents a linear or branched divalent group derived from a C 2 -C 6 alkyl group, R 5 represents a methyl, ethyl or propyl group, m is 1, and n represents an integer comprised between 1 to 3.
  • P is a group of formula (P-2) as defined above
  • X represents a functional group of formula ii)
  • R represents a linear or branched divalent group derived from a C 2 -C 6 alkyl group
  • R 5 represents a methyl, ethyl or propyl group
  • m represents 1, and n represents an integer comprised between 1 to 3.
  • each of the various P may be identical or different, as well as each of the X, R, R 5 or R 6 groups.
  • the delivery system according to the invention may be synthesized using conventional methods. Indeed, the delivery system
  • the reaction being carried out in a solvent having a dielectric constant ⁇ comprised between 3 and 81, at a temperature comprised between 20° and 70°C.
  • said reaction can be carried out in the presence of a weak acid or base.
  • the invention's delivery system is also obtainable by a process comprising the reaction between a nano particle together with at least one molar equivalent of a compound of formula
  • Y is a XH or COOR functional group or represents a C 5 -C carboxyhc anhydride, and X, m, R, R 5 and R 6 have the same meaning as indicated above; to obtain a derivatized nano particle, which is subsequently reacted with a compound of formula (IN) or (TV') as defined below, under reactions conditions similar to those susceptible of leading to a Michael addition, i.e. conditions which are for instance used in the preparation of compounds (UP) and which are described further below.
  • the first method of preparation is preferred.
  • the invention delivery system comprises at least one releasing moiety, and in the preparation of said delivery system a nano particle is reacted with at least one molar equivalent of the compound of formula (III) or (LU').
  • at least one it is meant here an amount comprised between 1 and y, y representing ideally the maximum number of releasing moieties or molar equivalent which can be covalently bonded to said nano particle.
  • y representing ideally the maximum number of releasing moieties or molar equivalent which can be covalently bonded to said nano particle.
  • the maximum number of releasing moieties, which can be attached to the nano particle will depend on the surface of the nano particle used and on the volume of said releasing moieties.
  • Suitable solvents for the synthesis of the invention's delivery system are water, linear, branched or cyclic mono-, di-, hi-, oligo- and polyalcohols with a monomer chain length of Ci to C 15 , preferably from Ci to C 5 , or C ⁇ to C 8 ketones, esters, ethers, carbon acids or yet mixtures thereof.
  • solvents selected from the group consisting of water, ethanol, metlianol, n-propanol, iso-propanol, n-decanol, dimethyl-ether, methyl-ethyl-ether, glycerol, dipropyl-glycol, 1,2-ethandiol, polyvinylalcohol.
  • organic or inorganic acid or base it is possible to use an organic or inorganic acid or base.
  • acids like hydrochloric acid, acetic acid, citric acid and bases like ammonia, sodium hydroxide, potassium hydroxide, tetramethyl ammonium hydroxide for the synthesis of the invention's delivery system.
  • the compounds of formula (HI) can be prepared using conventional methods, as illustrated herein below and in the examples.
  • the compounds (in) wherein X represents a sulfur atom, an oxygen atom or a NR 6 group are obtainable by the [l,4]-addition reaction, optionally in the presence of a base, between a thiol, alcohol or respectively an a ine, of general formula (H-X) m -R-Si(OR 5 ) 3 such as one of formula HSRSi(OR 5 ) 3 , HORSi(OR 5 ) 3 or HNR 6 RSi(OR 5 ) , and the active enone to be released by the invention's delivery systems, for instance an odoriferous ⁇ , ⁇ -unsaturated ketone, aldehyde or carboxyhc ester of formula (IN)
  • R, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 have the meaning indicated above and the configuration of the carbon-carbon double bond can be of the E or Z type.
  • the compounds of formula (HP) wherein X is a functional group of formula v) or vi) are obtainable, using standard methods, by oxidation of the corresponding system in which X is a sulfur atom.
  • the compounds of formula (IH) wherein X represents a carboxyhc functional group can be obtained more advantageously by the reaction between an appropriate compound of formula (HI'), such as ClCORSi(OR 5 ) 3 or EtOCORSi(OR 5 ) 3 , and a compound of formula (IN'), which is the aldol derivative of the odoriferous compound of formula (IV),
  • an appropriate compound of formula (HI') such as ClCORSi(OR 5 ) 3 or EtOCORSi(OR 5 ) 3
  • a compound of formula (IN') which is the aldol derivative of the odoriferous compound of formula (IV)
  • a particular example can be for instance the following:
  • aldol derivatives of formula (TV) of the latter compounds are also useful in the synthesis of the invention compounds.
  • the preferred are: ⁇ -damascone, (-)-alpha-damascone, ⁇ -damascone, ⁇ -damascone, ⁇ -damascone, trans ⁇ -damascone, ⁇ -ionone, ⁇ -ionone, ⁇ -damascenone, l-(5,5-dimethyl-l-cyclohexen-l- yl)-4-penten-l-one, l-(2,2,3,6-tetramethyl-l-cyclohexyl)-2-buten-l-one, 4-(2,2,3,6- tetramethyl-l-cyclohexyl)-3-buten-2-one or its trans isomer, l(6),8-P-menthadien-2-
  • the delivery system of the invention is composed of two main moieties, namely a nano particle moiety and a releasing moiety.
  • the latter moiety comprises a release part P-X and a linker part R-Si(OR 5 ) 3-n (O ⁇ ) n .
  • the invention's delivery systems are capable of releasing, via a decomposition reaction, a residue and an active enone of formula (IV).
  • An example of said decomposition reaction is illustrated in the following scheme:
  • X, R, R 1 , R 2 , R 3 and R 4 have the meaning indicated above and NP stand for nano particle moiety.
  • the nature of X plays an important role in the release kinetics of the active molecule.
  • the second part of the releasing moiety of the delivery system of the invention is the linker R-Si(OR 5 ) 3- ⁇ (O ⁇ ) n -
  • said linker part can have also an influence in the releasing properties of the invention's delivery system. Indeed, a shrewd choice of the chemical nature of said fragment, e.g.
  • the second moiety of the invention's delivery system is the nano particle moiety. If the invention's delivery system is intended to release a perfuming ingredient, according to a preferred embodiment of the invention, said moiety plays an important role in the effective deposition of the pro-perfume onto a surface and in surface substantivity of the invention's delivery system on the surface treated during an application, especially on fabrics and hair. Moreover it plays a capital role as regards the stability of the product into which the invention's delivery system may be incorporated, avoiding the problems of the above mentioned prior art pro-perfume systems, wherein the pro-perfume was at least partially adsorbed onto silica pores.
  • the decomposition reaction which leads to the release of the active enone, is beheved to be influenced by pH changes or heat, but may be triggered by other types of mechanisms.
  • the delivery system of the invention can be a useful ingredient for the perfuming of various products or surfaces
  • the invention concerns also the use of a invention's delivery system as perfuming ingredients.
  • a method to confer, enhance, improve or modify the odor properties of a perfuming composition or of a perfumed article which method comprises adding to said composition or article an effective amount of at least an invention's delivery system.
  • use of an invention's delivery system it has to be understood here also the use of any composition containing said delivery system and which can be advantageously employed in perfumery industry as active ingredients.
  • compositions which in fact can be advantageously employed as perfuming ingredient, are also an object of the present invention. Therefore, another object of the present invention is a perfuming composition
  • a perfuming composition comprising: i) as perfuming ingredient, at least an invention's delivery system of formula (I) as defined above, provided that P is a group of formula (IT) as defined above; ii) at least one ingredient selected from the group consisting of a perfumery carrier and a perfumery base; and iii) optionally at least one perfumery adjuvant.
  • perfumery carrier we mean here a material which is practically neutral from a perfumery point of view, i.e. that does not significantly alter the organoleptic properties of perfuming ingredients.
  • Said carrier may be a liquid.
  • liquid carrier one may cite, as non-limiting examples, an emulsifying system, i.e. a solvent and a surfactant system, or a solvent commonly used in perfumery.
  • emulsifying system i.e. a solvent and a surfactant system
  • a solvent commonly used in perfumery A detailed description of the nature and type of solvents commonly used in perfumery cannot be exhaustive.
  • solvents such as dipropyleneglycol, diethyl phthalate, isopropyl myristate, benzyl benzoate, 2-(2- ethoxyethoxy)-l-ethanol or ethyl citrate, which are the most commonly used.
  • suitable liquid carrier is water or a water-based medium.
  • perfumery base we mean here a composition comprising at least one perfuming co-ingredient.
  • Said perfuming co-ingredient is not an invention's delivery system.
  • perfuming co-ingredient it is meant here a compound, which is used in perfuming preparation or composition to impart a hedonic effect.
  • a co- ingredient to be considered as being a perfuming one, must be recognized by a person skilled in the art as being able to impart or modify in a positive or pleasant way the odor of a composition, and not just as having an odor.
  • perfuming co-ingredients present in the base do not warrant a more detailed description here, which in any case would not be exhaustive, the skilled person being able to select them on the basis of its general knowledge and according to intended use or application and the desired organoleptic effect.
  • these perfuming co-ingredients belong to chemical classes as varied as alcohols, aldehydes, ketones, esters, ethers, acetates, nitriles, terpene hydrocarbons, nitrogenous or sulphurous heterocyclic compounds and essential oils, and said perfuming co-ingredients can be of natural or synthetic origin. Many of these co-ingredients are in any case listed in reference texts such as the book by S.
  • compositions which comprise both a perfumery carrier and a perfumery base can be also ethanol, water/ethanol mixtures, limonene or other terpenes, isoparaffins such as those known under the trademark Isopar ® (origin: Exxon Chemical) or glycol ethers and glycol ether esters such as those known under the trademark Dowanol ® (origin: Dow Chemical Company).
  • isoparaffins such as those known under the trademark Isopar ® (origin: Exxon Chemical) or glycol ethers and glycol ether esters such as those known under the trademark Dowanol ® (origin: Dow Chemical Company).
  • perfumery adjuvant we mean here an ingredient capable of imparting additional added benefit such as a color, a particular light resistance, chemical stability and etc.
  • An invention's composition consisting of at least one compound of formula (I) and at least one perfumery carrier represents a particular embodiment of the invention as well as a perfuming composition comprising at least one compound of formula (I), at least one perfumery carrier, at least one perfumery base, and optionally at least one perfumery adjuvant.
  • a particular perfuming composition comprises: i) as perfuming ingredient, at least an invention's delivery system as defined above, provided that P is a group of formula (H) as defined above; ii) water; and iii) optionally at least an anti-floculant ingredient.
  • Anti-fioculant ingredients are compound well known per se by a person skilled in the art.
  • a suitable anti-floculant ingredient is the high molecular weigh co-polymer known under the name Disperbyk-190 (origin: Byk Chemie).
  • an invention's delivery system in any of its above- mentioned forms, is a useful perfuming ingredient which can be advantageously used in all the fields of modern perfumery, such as fine perfumery or functional perfumery, as it enables a controlled release of odoriferous molecules.
  • the invention's delivery system may be advantageously employed in fine or functional perfumery to achieve a more controlled deposition and/or release, of an active perfuming ingredient.
  • perfuming ingredients present as such in washing or perfuming compositions can have little staying-power on a surface and consequently be often eliminated, for example in the rinsing water or upon drying of said surface.
  • the invention's delivery system owing to a good substantivity, a low volatility and a controlled release of odoriferous molecules, can be incorporated in any application requiring the effect of rapid or prolonged release of an odoriferous component as defined hereinabove and furthermore can impart a fragrance and a freshness to a treated surface which will last well beyond the rinsing and/or drying processes.
  • Suitable surfaces are, in particular, textiles, hard surfaces, hair and skin.
  • one of the major advantages of the invention resides in the fact that the invention's delivery system imparts an intense fragrance to the treated surface, produced by an odoriferous enone, which would not be detected on said surface over a sufficiently long period if the ⁇ , ⁇ -unsaturated carbonyl derivative of formula (IN) had been used as such, i.e. without a precursor. Therefore, another object of the present invention is a perfumed article comprising: i) as perfuming ingredient at least one invention's delivery system as defined above, provided that P is a group of formula (H) as defined above; and ii) a consumer product base; is also an object of the present invention.
  • a consumer product base we mean here a consumer product, i.e. a consumable product such as a detergent or a perfume.
  • a perfumed article according to the invention comprises the functional formulation, as well as optionally additional benefit agents, corresponding to a consumer product, e.g. a detergent or an air freshener, and an olfactive effective amount of at least one invention's delivery system.
  • a consumer product e.g. a detergent or an air freshener
  • an olfactive effective amount of at least one invention's delivery system e.g. a detergent or an air freshener
  • the nature and type of the constituents of the consumer product do not warrant a more detailed description here, which in any case would not be exhaustive, the skilled person being able to select them on the basis of its general knowledge and according to the nature and the desired effect of said product.
  • suitable perfumed articles include solid or liquid detergents and fabric softeners as well as all the other articles of common use in perfumery, namely perfumes, colognes or after-shave lotions, perfumed soaps, shower or bath salts, mousses, oils or gels, hygiene products or hair care products such as shampoos, body-care products, deodorants or antiperspirants, air fresheners and also cosmetic preparations.
  • perfumes there are intended applications such as detergent compositions or cleaning products for washing up or for cleaning various surfaces, e.g. intended for textile, dish or hard-surface treatment, whether they are intended for domestic or industrial use.
  • Other perfumed articles are fabric refreshers, ironing waters, papers, wipes or bleaches.
  • Preferred articles are perfumes, fabric detergents or softener bases.
  • Typical examples of fabric detergents or softener compositions into which the compounds of the invention can be incorporated are described in WO 97/34986 or in US patents 4,137,180 and 5,236,615 or EP 799 885.
  • Other typical detergent and softening compositions which can be used are described in works such as Ullman's Encyclopedia of Industrial Chemistry, vol. A8, pages 315 - 448 (1987) and vol. A25, pages 747 - 817 (1994); Flick, Advanced Cleaning Product Formulations, Noye Publication, Park Ridge, New Jersey (1989); Showell, in Surfactant Science Series, vol.
  • a further object of the present invention concerns the use of a delivery system as defined above, wherein P is derived from an active therapeutical steroid, as a pharmaceutical agent. Furthermore, the present invention concerns also a pharmaceutical composition comprising a delivery system according to the second main embodiment of the invention.
  • the invention will now be described in further detail by way of the following examples, wherein the abbreviations have the usual meaning in the art, the temperatures are indicated in degrees centigrade (°C) ; the ]MMR spectral data were recorded in CDC1 3 1 1 ⁇
  • component 1 315 g tetraethoxysilane (1.27 mol) are mixed with 782 g ethanol (17 mol) (component 1). Separately, 21.23 g of a 35% w/w aqueous solution of ammonia were diluted with 498 g of water (component 2). Component 2 is mixed under vigorous stirring with component 1.
  • the mixture thus obtained is heated up to 70° C for 8 hours. Afterwards, to the mixture thus obtained were added 9.5 g of Polyoxyethylene sorbitan monooleate (Tween 80, origin ICI), and the mixture was heated under stirring in an autoclave for 4 hours at 230° C, while mamtaining the pressure between 30 and 40 bar. To remove the precipitated powder from the solvent decanting and filter pressing has been used. The so prepared SiO 2 powders have been mixed with 12 % w/w, relative to the amount of powder, of the surface modifier Polyoxyethylene sorbitan monooleate (Tween 80), and dipropylene glycol was added.
  • Teween 80 Polyoxyethylene sorbitan monooleate
  • Mortary mill This is a milling machine form by a round Zirconium container.
  • a round Zirconium pistil is set very close (2 ⁇ m) to one side of the pot and is touching the bottom of the container.
  • the container turns with 120 rpm while the pistil is pressed to the bottom of the container with a force of 10 N (1kg).
  • N 10 N
  • the starting nano particle has no Zero cross over at any pH value while the treated one has a Zero cross over at the pH value of 3. This is a certain indication that the pro-perfume has been bound chemically to the particle, otherwise the zeta potential would only slightly be changed in the measured pH range.
  • the density of the so modified material changed slightly to 2.27 g/cm 3 , while the surface area decreased to 37.4 m 2 /g.
  • the particles did not grow during the modification process and still showed a main primary particle size of 20 to 50 nm.
  • the untreated SiO 2 has no Zero cross over at any pH value while the treated one has a Zero cross over at the pH value of 3. This is a certain indication that the pro-perfume has been bound chemically to the particle, otherwise the zeta potential would only slightly be changed in the measured pH range.
  • the density and the surface area of this invention's delivery system are similar to those of the one described in example 2.b.i).
  • the untreated SiO 2 has no Zero cross over at any pH value while the treated one has a Zero cross over at the pH value of 3. This is a certain indication that the pro-perfume has been bound chemically to the particle, otherwise the zeta potential would only slightly be changed in the measured pH range.
  • the density and the surface area of this invention's delivery system are similar to those of the one described in example 2.b.i).
  • the untreated SiO 2 has no Zero cross over at any pH value while the treated one has a Zero cross over at the pH value of 3. This is a certain indication that the pro-perfume has been bound chemically to the particle, otherwise the zeta potential would only slightly be changed in the measured pH range.
  • the density and the surface area of this invention's delivery system are similar to those of the one described in example 2.b.i).
  • a dispersion of a delivery system according to the invention in DIPG c) were added to 85 g of unperfumed market powder detergent "Via” (Lever Faberge AB, Sweden).
  • the perfumed detergent was introduced in the powder compartment of a Miele Novotronic W900-79 CH washing machine. No fabric-softener was used. The machine was loaded with 16 terry towels (28x28cm, about 40g each) and approx. 2.3kg of cotton towels (11 towels, sized 45x85cm). This load was washed at 40°C using the normal cycle program and setting the spin drying adjustment to 900 rpm.
  • the 16 terry towels were line-dried, in a drying room for 24 hours before being evaluated by a 20 people panel. They were then packed loosely in aluminum foil and further evaluated by a 20 people panel after 1, 4 and 7 days. Each panelist was asked to rate the various terry towels tested on an intensity scale of 1 to 7. 1 : no odor, 2 : weak odor, 3 : slightly weak odor, 4 : medium odor, 5 : slightly strong odor, 6 : strong odor, 7 : very strong odor.
  • Table 1 Average value of the intensity rated by panelists over 7 days
  • both delivery systems according to the invention are able to impart to a fabric a significantly more intense odor, than the active compound as such. This effect being present over a long period of time.
  • Example 4
  • a concentrated fabric softener base was prepared by admixing the following ingredients:
  • the delivery system according to the invention in the form of a dispersion in DIPG, was added to 36 g of fabric-softener base above. After a vigorous stirring the mixture was poured in the fabric-softener compartment of a Miele Novotronic W900-79 CH washing machine. No detergent is applied.
  • Table 2 Average intensity rating of all three evaluations on dry fabric (1, 3 and 7 days after the wash)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)

Abstract

Nano-sized delivery systems consisting of an inorganic nano particle moiety covalently bonded to at least one organic pro-perfume or pro-drug moiety are disclosed. The systems of the invention are able to deliver perfuming or pharmaceutical active ingredients. Other aspect of the present invention, for instance, are the use of said systems in perfumery as well as the perfuming compositions or perfumed articles comprising the invention's delivery systems.

Description

PERFUME DELIVERY SYSTEMS BASED ON INORGANIC NANO PARTICLES
Technical field
The present invention relates to the field of the chemical delivery systems, and more precisely to the perfumery and pharmaceutical fields. The invention concerns a delivery system which comprises a nano particle moiety and a releasing moiety. The invention's delivery system is capable of liberating in a controlled manner an active compound belonging to the α,β-unsaturated etone, aldehyde or carboxylic ester families. The present invention concerns also the use of said delivery system as perfuming ingredient as well as the perfuming compositions or perfumed articles comprising the invention's delivery system. Other objects of the invention are pharmaceutical compositions or drugs comprising the invention's delivery system.
Prior art
Inorganic materials have been described in the prior art as useful carriers for active ingredients. In particular silica has been widely disclosed as carrier for perfumes or perfume precursors, also referred to as "pro-perfumes". For instance WO 01/83398 discloses a delivery system consisting of porous silica carrying pro-perfumes. According to this document, the pro-perfumes are either adsorbed in silica pores, or chemically bonded after chemical modification of the pores' surface. Although the size of the silica particles is not specifically cited in this document, it can be deduced from the description of silica pores that the systems are certainly on a micron scale. As a consequence, the particles are not able to form solid suspensions in a liquid. Moreover, when used in application such as in a cleaning or detergent product, due to their size, the disclosed delivery systems present the risk of leaving residues on the treated surfaces, for instance a fabric in the case of a detergent. Finally, these systems also present stability problems, as the pro-perfumes adsorbed within the pores of the inorganic material are susceptible to diffuse in the environment during a prolonged storage. To the best of our knowledge, systems based on other inorganic materials do not solve these problems. The present invention now provides a solution to the above-mentioned problems, thanks to a delivery system which is on a nanosize scale and which comprises an inorganic nano particle moiety covalently bonded to at least one organic releasing moiety. This covalent bonding allows a better stability during storage, as well as a better control of the release of the perfume. On the other hand the nano-size of the particles allows using the delivery systems of the invention in the form of solid dispersions in a liquid. Systems on a nanosize scale have been described in the prior art. i particular WO 02/50230 or yet DE 19841147 disclose "nano" systems. However the latter documents are based on the use of organic carriers, i.e. polymers or oligomers dissolved in one phase. These carriers are therefore dispersed in water so as to form nanoemulsions. The problems encountered by these systems come from the fact that a nanoemulsion is a liquid system which is, by virtue of its nature, susceptible of being destabilized easily when used in an application, for instance in the presence of a surfactant system. In particular, coalescence, and ripening may be cited as examples of such destabilization phenomena and they consequently alter the nanometric distribution of the emulsion system. The present invention provides a solution to said problem with the use of an inorganic carrier such as SiO2, which is modified in its surface so as to be covalently bonded with organic moiety such as pro-perfumes. Contrary to the cited prior art the inorganic nature of the carrier allows to prepare solid dispersions which are much more stable than emulsion-type systems and which present, as a consequence, a stable nanometric distribution.
Description of the invention
We have therefore surprisingly discovered that a delivery system comprising a nano particle moiety covalently bonded to at least one β-oxy, β-thio or β-amino carbonyl moiety is a valuable perfuming or therapeutical ingredient capable of liberating in a controlled manner an active compound. Furthermore, as "active compound" we mean here a compound capable of bringing a benefit into the surrounding environment into which is it released by the invention's delivery system. Said benefit could be related to an olfactif effect, e.g. an odor, or to a therapeutical effect. Therefore, said "active compound" can be an active perfuming ingredient or an active therapeutical ingredient. In the present invention said active compound is an active α,β-unsaturated ketone, aldehyde or carboxylic ester, preferably an active α,β-unsarurated ketone or aldehyde. In a first embodiment of the invention, said active compound is a perfuming ingredient. By "perfuming ingredient" it is meant here a compound, which is of current use in the perfumery industry, i.e. a compound which is used as active ingredient in perfuming preparations or compositions in order to impart a hedonic effect. In other words such an ingredient, to be considered as being a perfuming one, must be recognized by a person skilled in the art of perfumery as being able to impart or modify in a positive or pleasant way the odor of a composition, and not just as having an odor. In a second embodiment of the invention, said active compound is a therapeutical ingredient. By "therapeutical ingredient" it is meant here a compound, which is of current use in the pharmaceutical industry, i.e. a compound which is incorporated into a pharmaceutical preparation, as active ingredient, to treat a disease or pain. In other words such an ingredient, to be considered as being a therapeutical one, must be recognized by a person skilled in the art of pharmacy as being able to provide a positive effect to the health of a patient. As mentioned above, the delivery system of the invention comprises a nano particle moiety. Said moiety constitutes the inorganic part of the invention's delivery system and is a mono or multi radical, depending on the number of releasing moieties bonded to it. Said moiety is derived from an inorganic nano particle. By "nano particle" we mean here a particle having a mean particle size comprised between 2 run and 500 nm, measured with the Microtrac Ultrafine Particle Analyser (UP A). Preferably the size is comprised between 15 nm and 50 nm. The inorganic nario particle, from which the nano particle moiety can be derived, can be made from inorganic materials such as amorphous or crystalline metal oxides, hydroxides, oxo-hydroxides or mixtures thereof. Suitable examples of such metals are elements of the I, II, HI or IV main group, e.g. Al, Si, hi, Sn, Ca, Ba or Sr, or yet the transition elements, e.g. Ti, Zr, Fe, Ag or Zn. Particularly suitable nano particle moieties are those derived from a nano particle made from oxides or hydroxides of Ti, Si, Zr, Al, Fe or mixtures thereof. More specifically, for their use in perfumery, the nano particles moieties made from oxides or hydroxides of Si, e.g. silica, are especially suitable for the purpose of the invention, whereas for a pharmaceutical application, it is preferable to use Si or Fe based nano particle moieties. According to a particular embodiment of the invention the nano particle, from which the nano particle moiety is derived, has X-ray diffraction characteristics, measured with a Siemens D500 X-ray diffractometer with Cu-Kα radiation and scintillation counter, in the 2Θ range between 15° and 85°. Said 2Θ range indicates that the spherical nano particles made of silica are mainly amorphous. Density can also be used to characterise the nano particles. For instance a nano particle made from silica may have a density comprised between 2 and 2.4 g/cm3, preferably between 2.2 and 2.3 g/cm3, while a nano particle made from titanium oxide may have a density ranging from 3.8 to 4.3 g/cm3, preferably from 3.8 to 3.9 g/cm3, or yet the nano particle made from alumina may have a density ranging from 3.8 to 4.2 g/cm3. Alternatively a nano particle made from iron oxide may have a density comprised between 5.0 and 6.0 g/cm3. In the case of a nano particle made from silica, which represents a preferred embodiment of the invention, the specific surface area, as measured by He-gas pycnometer AccuPyc 1330 from Micromeritics, is comprised between approximately 20 and 200 m2/g, preferably between 40 and 60 m2/g. Moreover, the surface charge of the particle is negative and the Zeta potential, measured with Malvern Zetasizer 2000, does not reveal no-charge point in the range from pH 2 to pH 11. This inorganic nano particle moiety is covalently bonded by means of n (Si-O)- bondsto at least one releasing moiety of formula (P-X)m-R-Si(OR5)3-n(O→)n (I) wherein the arrow indicates the location of the bond between said releasing moiety and the nano particle moiety, n representing an integer comprised between 1 to 3, and wherein a) P represents a group derived from a active perfume ingredient and which is represented by formula (H)
Figure imgf000006_0001
in which the wavy line indicates the location of the bond between said P and X; R1 represents a hydrogen atom, a to Ce alkoxyl radical or a d to C15 linear or branched or cyclic alkyl, alkenyl or alkadienyl group, optionally substituted by one to four Ci to C4 alkyl groups; and R2, R3 and R4 represent a hydrogen atom, a C6-8 aromatic ring or a Ci to C15 linear, cyclic or branched alkyl, alkenyl or alkadienyl group, optionally substituted by one to four Ci to C4 alkyl groups; two, or three, of said R1 to R4 being optionally bonded together to form a saturated or unsaturated ring having 6 to 20 carbon atoms and including the carbon atom to which said R1, R2, R3 or R4 groups are bonded, this ring being optionally substituted by one to four Ci to C linear or branched alkyl or alkenyl groups; or P represents a group derived from an active therapeutical steroid and is represented by formula
Figure imgf000006_0002
in which the wavy line indicates the location of the bond between said P and X; R10 represents a hydrogen atom or a hydroxy group; A represents a CH2, C=O or CH2OH group; and R11 represents a hydrogen atom or a C≡CH, CH3CO or HOCH2CO group; b) X represents a functional group selected from the group consisting of the formulae i) to vi):
Figure imgf000007_0001
ϋ) iii)
Figure imgf000007_0002
iv) v) vi) in which formulae the wavy lines are as defined previously and the bold lines indicate the location of the bond between said X and R, and R6 represents a hydrogen atom or a Ci to C alkyl group; c) R represents a linear, branched or cyclic multivalent group (with a m+1 valence) derived from a -C15 alkyl or alkylaryl group, said group optionally containing one or two functional groups selected from the group consisting of oxygen and sulfur atoms, CO, COO, CONR6, COS and N{R6)a, R6 being defined as above and a representing 0 or 1, d) R5 represents a linear or branched Ci to C alkyl group; and e) m represents 1, 2 or 3. According to a first embodiment of the invention, P in formula (I) is a group derived from an active perfuming α,β-unsaturated ketone, aldehyde or carboxyhc ester having from 8 to 20 carbon atoms, or more preferably between 11 and 15 carbon atoms. According to a second embodiment, P is a group derived from a therapeutical α,β-unsaturated steroid having from 19 to 26 carbon atoms, or more preferably between 19 and 21 carbon atoms. According to a particular mode of realisation of said first embodiment of the invention, i.e. when the active compound is a perfuming ingredient, the invention's delivery system will preferably comprise a releasing moiety (I) wherein P is a group selected from the group consisting of the formulae (P-l) to (P-12)
Figure imgf000008_0001
(P-l) CP-2) (P-3) CM)
Figure imgf000008_0002
Figure imgf000008_0004
Figure imgf000008_0003
(P-9) CP-10)
Figure imgf000008_0005
(P-12)
in the form of any one of their isomers, and wherein the dotted lines represent a single or double bond, R represents a methyl or ethyl group, R represents a C6 to C9 lmear or branched alkyl, alkenyl or alkadienyl group and R9 represents a hydrogen atom or a methyl group, and the wavy lines have the meaning defined previously. In a more particular realization of said mode, there will be used a releasing moiety (I) wherein P is a group selected from the group consisting of the formulae (P-l) to (P-7), as defined above, or more preferably of the formulae CP-1), (P-5), and (P-7). In the second invention's embodiment, i.e. when the active enone is a therapeutical ingredient, there will be preferably used a releasing moiety (I) wherein P is a group of formula (P-13) or (P-14)
Figure imgf000009_0001
(P-13) (P-14)
in the form of any one of their isomers, and wherein, R10 and R11 having the meaning indicated above and B representing a C=O or CH2OH group. Independently of the exact nature of P, in the invention's delivery systems described above, the X group is preferably selected from the group consisting of formulae i), ii) and iii), as defined above, R6 representing a hydrogen atom or a methyl or ethyl group. More preferably, X represents a group of formula ii) or iii), as defined above, R6 representing a hydrogen atom or a methyl or ethyl group. Furthermore, in the delivery systems described above, preferably, R represents a linear, branched or cyclic divalent or trivalent group derived from a C2-C9 alkyl group, said group optionally containing one or two functional groups selected from the group consisting of oxygen and sulfur atoms, COO, CONR6, and N(R6)a, R6 being defined as above and a representing 0 or 1, R5 represents a methyl, ethyl or propyl group, and m is 1 or 2. More preferably, R represents a linear, branched or cyclic divalent group derived from a C2-C6 alkyl group optionally containing one functional groups selected from the group consisting of oxygen and sulfur atoms, COO, and N(R6)a, R6 being defined as above and a being 1, R5 represents a methyl, ethyl or propyl group, and m is 1. According a particular mode of realisation of the invention, the invention's delivery system is one wherein P is a radical of formula (P-l) or (P-7), as defined above; X represents a functional group of formula ii) or iii), R6 representing a hydrogen atom; R represents a linear or branched divalent group derived from a C2-C6 alkyl group; R5 represents a methyl, ethyl or propyl group; and m is 1, and n represents 1, 2 or 3. Alternatively, a further particularly appreciated delivery system is one wherein P is a group of formula (P-2) as defined above, X represents a functional group of formula ii), R represents a linear or branched divalent group derived from a C2-C6 alkyl group, R5 represents a methyl, ethyl or propyl group, m is 1, and n represents an integer comprised between 1 to 3. Independently from the embodiment of the invention, it is understood that whereas the invention's delivery system comprises more than one releasing moiety, then each of the various P may be identical or different, as well as each of the X, R, R5 or R6 groups. The delivery system according to the invention may be synthesized using conventional methods. Indeed, the delivery system corresponding to any of the invention's embodiments is obtainable by a process comprising the reaction between a nano particle, as described above, with at least one molar equivalent of a compound of formula
(p-x)m-R-si(OR5)3 (πr>
wherein m, P, X, R and R5 have the meaning indicated above; the reaction being carried out in a solvent having a dielectric constant ε comprised between 3 and 81, at a temperature comprised between 20° and 70°C. Optionally, said reaction can be carried out in the presence of a weak acid or base. Alternatively, the invention's delivery system is also obtainable by a process comprising the reaction between a nano particle together with at least one molar equivalent of a compound of formula
(Y)m-R-si(OR5)3 cπr)
wherein Y is a XH or COOR functional group or represents a C5-C carboxyhc anhydride, and X, m, R, R5 and R6 have the same meaning as indicated above; to obtain a derivatized nano particle, which is subsequently reacted with a compound of formula (IN) or (TV') as defined below, under reactions conditions similar to those susceptible of leading to a Michael addition, i.e. conditions which are for instance used in the preparation of compounds (UP) and which are described further below. According to a particular embodiment of the invention, the first method of preparation is preferred. It has been mentioned above, that the invention delivery system comprises at least one releasing moiety, and in the preparation of said delivery system a nano particle is reacted with at least one molar equivalent of the compound of formula (III) or (LU'). For sake of clarity, it has to be mentioned that by "at least one" it is meant here an amount comprised between 1 and y, y representing ideally the maximum number of releasing moieties or molar equivalent which can be covalently bonded to said nano particle. As a person skilled in the art is aware, it is not possible to give an exact value to y. Indeed, the maximum number of releasing moieties, which can be attached to the nano particle, will depend on the surface of the nano particle used and on the volume of said releasing moieties. However, as non-limiting examples, one can cite invention delivery systems wherein the nano particle moiety is covalently bonded to up to 2.2 releasing moieties per nm2 of free surface area of the nano particles moiety (at a surface area of 50 m2/g this corresponds to 1.1x10 releasing moieties per gram of starting nano particle). Suitable solvents for the synthesis of the invention's delivery system are water, linear, branched or cyclic mono-, di-, hi-, oligo- and polyalcohols with a monomer chain length of Ci to C15, preferably from Ci to C5, or C\ to C8 ketones, esters, ethers, carbon acids or yet mixtures thereof. As non limiting examples one may cite the solvents selected from the group consisting of water, ethanol, metlianol, n-propanol, iso-propanol, n-decanol, dimethyl-ether, methyl-ethyl-ether, glycerol, dipropyl-glycol, 1,2-ethandiol, polyvinylalcohol. If desired it is possible to use an organic or inorganic acid or base. As non-limiting examples one may cite acids like hydrochloric acid, acetic acid, citric acid and bases like ammonia, sodium hydroxide, potassium hydroxide, tetramethyl ammonium hydroxide for the synthesis of the invention's delivery system. The compounds of formula (HI) can be prepared using conventional methods, as illustrated herein below and in the examples. For instance, the compounds (in) wherein X represents a sulfur atom, an oxygen atom or a NR6 group are obtainable by the [l,4]-addition reaction, optionally in the presence of a base, between a thiol, alcohol or respectively an a ine, of general formula (H-X)m-R-Si(OR5)3 such as one of formula HSRSi(OR5)3, HORSi(OR5)3 or HNR6RSi(OR5) , and the active enone to be released by the invention's delivery systems, for instance an odoriferous α,β-unsaturated ketone, aldehyde or carboxyhc ester of formula (IN)
Figure imgf000012_0001
(IV)
wherein R, R1, R2, R3, R4, R5 and R6 have the meaning indicated above and the configuration of the carbon-carbon double bond can be of the E or Z type. The compounds of formula (HP) wherein X is a functional group of formula v) or vi) are obtainable, using standard methods, by oxidation of the corresponding system in which X is a sulfur atom. Furthermore, the compounds of formula (IH) wherein X represents a carboxyhc functional group can be obtained more advantageously by the reaction between an appropriate compound of formula (HI'), such as ClCORSi(OR5)3 or EtOCORSi(OR5)3, and a compound of formula (IN'), which is the aldol derivative of the odoriferous compound of formula (IV),
Figure imgf000012_0002
R, R1, R2, R3, R4 and R5 having the meaning indicated above. The compounds of formula (HI') are generally commercially available or obtainable according to standard methods which are well known by a person skilled in the art. Examples of the synthetic approach described above, for particular cases of starting materials, are illustrated in the following scheme:
Figure imgf000013_0001
A particular example can be for instance the following:
Figure imgf000013_0002
Although it is not necessary to provide an exhaustive list of the compounds of formula (H-X)mRSi(OR5)3 or of formula (HI') which may be used in the synthesis of the various intermediates or delivery systems, one can cite as preferred examples the thiols of formula (R5O)3Si-(CH2-3-SH, the amines of the formulae (R5O)3Si-(CH2)3-4-NH2, (R5O)3Si-(CH2)2-3-NH-(CH2)2-6-NH2, (R5O)3Si-(CH2)2-3-N[-(CH2)2-6-NH2]2, (R5O)3Si- (CH2-2-(CHMe)1-2-(CH2)1-2-NH2, (R5O)3Si-(CH2)2-3-(C6H4)-(CH2)1-2-NH2 or (R5O)3Si- (CH2)2-3-(C6H4)-(CH2)1-2-NH-(CH2)2-3-NH2, the alcohols of the formulae (R5O)3Si- (CH2)1-3-OH, (R5O)3Si-(CH2)2-3-N[-(CH2)2-6-OH]2 or (R5O)3Si-(CH2)2-3-NCO-(CH2)1-4- OH, or the esters or anhydrides of the formulae (R5O)3Si-(CH2)2-3-CH(COOR6)2 or (R5O)3Si-(CH2)2-3-(2,5-(hoxo-furan-3-yl), R5 and R6 having the same meaning as indicated above. More preferably, one may cite in particular the thiols of the formulae (EtO)3Si- (CH2)i_3-SH or (MeO)3Si(CH2-3-SH, the amines of the formulae (MeO)3Si(CH2)3-4-NH2, (EtO)3Si-(CH2)3-4-NH2, (MeO)3Si-(CH2)3-NH-(CH2)2 or 6- H2, (MeO)3Si-(CH2)3-N[- (CH2)2 or 6-NH2]2, (MeO)3Si-CH2CHMe-(CH2)2-NH2, (MeO)3Si-(CH2)2-(C6H4)-CH2NH2 or (R5O)3Si-(CH2)2-(C6H4)-CH2 H-(CH2)2-3-NH2. Similarly, it is not possible to provide an exhaustive list of the currently active enones of formula (IV) which can be used in the synthesis of the invention's delivery systems, and subsequently be released. However, in the case where said compounds of formula (IN) are odoriferous enones, the following can be named as preferred examples: alpha-damascone, (-)-alpha-damascone, beta-damascone, gamma-damascone, delta- damascone, trans- delta-damascone, alpha-ionone, beta-ionone, gamma-ionone, delta- ionone, beta-damascenone, 3-methyl-5-propyl-2-cyclohexen-l-one, l(6),8-P-menthadien- 2-one, 2,5-dimethyl-5-phenyl-l-hexen-3-one, l-(5,5-dimethyl-l-cyclohexen-l-yl)-4- penten-1-one, 8 or 10-methyl-alpha-ionone, 2-octenal, l-(2,2,3,6-tetramethyl-l- cyclohexyl)-2-buten- 1 -one, 4-(2,2,3 ,6-tetramethyl- 1 -cyclohexyl)-3-buten-2-one, 2- cyclopentadecen-1-one, nootkatone, cinnamic aldehyde, 2,6,6-trimethyl- bicyclo[3.1.1]heptane-3-spiro-2'-cyclohexen-4'-one, ethyl 2,4-deca-dienoate, ethyl 2- octenoate, methyl 2-nonenoate, ethyl 2,4-undecadienoate and methyl 5,9-dimethyl-2,4,8- decatrienoate. Of course, the aldol derivatives of formula (TV) of the latter compounds are also useful in the synthesis of the invention compounds. Amongst the odoriferous compounds cited in the list hereinabove, the preferred are: α-damascone, (-)-alpha-damascone, β-damascone, γ-damascone, δ-damascone, trans δ-damascone, α-ionone, β-ionone, β-damascenone, l-(5,5-dimethyl-l-cyclohexen-l- yl)-4-penten-l-one, l-(2,2,3,6-tetramethyl-l-cyclohexyl)-2-buten-l-one, 4-(2,2,3,6- tetramethyl-l-cyclohexyl)-3-buten-2-one or its trans isomer, l(6),8-P-menthadien-2-one, and 2-cyclopentadecen-l-one. As it has been mentioned in the description above, the delivery system of the invention is composed of two main moieties, namely a nano particle moiety and a releasing moiety. Now, the latter moiety comprises a release part P-X and a linker part R-Si(OR5)3-n(O→)n. Owing to the particular chemical structure of the release part P-X the invention's delivery systems are capable of releasing, via a decomposition reaction, a residue and an active enone of formula (IV). An example of said decomposition reaction is illustrated in the following scheme:
Figure imgf000015_0001
(TV)
wherein X, R, R1, R2, R3 and R4 have the meaning indicated above and NP stand for nano particle moiety. The nature of X plays an important role in the release kinetics of the active molecule. Thus, through a careful choice of the nature of X it is possible to tune the release properties of the invention's delivery systems. The second part of the releasing moiety of the delivery system of the invention is the linker R-Si(OR5)3-π(O→)n- Besides its role as a linker between the releasing part P-X and the nano particle moiety, said linker part can have also an influence in the releasing properties of the invention's delivery system. Indeed, a shrewd choice of the chemical nature of said fragment, e.g. more or less flexible or hydrophobic/hydrophilic fragments, can allow to fine tune the perfume releasing properties. The second moiety of the invention's delivery system is the nano particle moiety. If the invention's delivery system is intended to release a perfuming ingredient, according to a preferred embodiment of the invention, said moiety plays an important role in the effective deposition of the pro-perfume onto a surface and in surface substantivity of the invention's delivery system on the surface treated during an application, especially on fabrics and hair. Moreover it plays a capital role as regards the stability of the product into which the invention's delivery system may be incorporated, avoiding the problems of the above mentioned prior art pro-perfume systems, wherein the pro-perfume was at least partially adsorbed onto silica pores. The decomposition reaction, which leads to the release of the active enone, is beheved to be influenced by pH changes or heat, but may be triggered by other types of mechanisms. As the delivery system of the invention can be a useful ingredient for the perfuming of various products or surfaces, the invention concerns also the use of a invention's delivery system as perfuming ingredients. In other words it concerns a method to confer, enhance, improve or modify the odor properties of a perfuming composition or of a perfumed article, which method comprises adding to said composition or article an effective amount of at least an invention's delivery system. By "use of an invention's delivery system" it has to be understood here also the use of any composition containing said delivery system and which can be advantageously employed in perfumery industry as active ingredients. Said compositions, which in fact can be advantageously employed as perfuming ingredient, are also an object of the present invention. Therefore, another object of the present invention is a perfuming composition comprising: i) as perfuming ingredient, at least an invention's delivery system of formula (I) as defined above, provided that P is a group of formula (IT) as defined above; ii) at least one ingredient selected from the group consisting of a perfumery carrier and a perfumery base; and iii) optionally at least one perfumery adjuvant. By "perfumery carrier" we mean here a material which is practically neutral from a perfumery point of view, i.e. that does not significantly alter the organoleptic properties of perfuming ingredients. Said carrier may be a liquid. As liquid carrier one may cite, as non-limiting examples, an emulsifying system, i.e. a solvent and a surfactant system, or a solvent commonly used in perfumery. A detailed description of the nature and type of solvents commonly used in perfumery cannot be exhaustive. However, one can cite as non-limiting example solvents such as dipropyleneglycol, diethyl phthalate, isopropyl myristate, benzyl benzoate, 2-(2- ethoxyethoxy)-l-ethanol or ethyl citrate, which are the most commonly used. Another example of suitable liquid carrier is water or a water-based medium. Generally speaking, by "perfumery base" we mean here a composition comprising at least one perfuming co-ingredient. Said perfuming co-ingredient is not an invention's delivery system. Moreover, by "perfuming co-ingredient" it is meant here a compound, which is used in perfuming preparation or composition to impart a hedonic effect. In other words such a co- ingredient, to be considered as being a perfuming one, must be recognized by a person skilled in the art as being able to impart or modify in a positive or pleasant way the odor of a composition, and not just as having an odor. The nature and type of the perfuming co-ingredients present in the base do not warrant a more detailed description here, which in any case would not be exhaustive, the skilled person being able to select them on the basis of its general knowledge and according to intended use or application and the desired organoleptic effect. In general terms, these perfuming co-ingredients belong to chemical classes as varied as alcohols, aldehydes, ketones, esters, ethers, acetates, nitriles, terpene hydrocarbons, nitrogenous or sulphurous heterocyclic compounds and essential oils, and said perfuming co-ingredients can be of natural or synthetic origin. Many of these co-ingredients are in any case listed in reference texts such as the book by S. Arctander, Perfume and Flavor Chemicals, 1969, Montclair, New Jersey, USA, or its more recent versions, or in other works of a similar nature, as well as in the abundant patent literature in the field of perfumery. It is also understood that said co-ingredients may also be compounds known to release in a controlled manner various types of perfuming compounds. For the compositions which comprise both a perfumery carrier and a perfumery base, other suitable perfumery carrier, than those previously specified, can be also ethanol, water/ethanol mixtures, limonene or other terpenes, isoparaffins such as those known under the trademark Isopar® (origin: Exxon Chemical) or glycol ethers and glycol ether esters such as those known under the trademark Dowanol® (origin: Dow Chemical Company). Generally speaking, by "perfumery adjuvant" we mean here an ingredient capable of imparting additional added benefit such as a color, a particular light resistance, chemical stability and etc. A detailed description of the nature and type of adjuvant commonly used in perfuming bases cannot be exhaustive, but it has to be mentioned that said ingredients are well known to a person skilled in the art. An invention's composition consisting of at least one compound of formula (I) and at least one perfumery carrier represents a particular embodiment of the invention as well as a perfuming composition comprising at least one compound of formula (I), at least one perfumery carrier, at least one perfumery base, and optionally at least one perfumery adjuvant. Moreover, according to a particular embodiment of the invention, a particular perfuming composition comprises: i) as perfuming ingredient, at least an invention's delivery system as defined above, provided that P is a group of formula (H) as defined above; ii) water; and iii) optionally at least an anti-floculant ingredient. Anti-fioculant ingredients are compound well known per se by a person skilled in the art. By means of examples a suitable anti-floculant ingredient is the high molecular weigh co-polymer known under the name Disperbyk-190 (origin: Byk Chemie). It is also useful to mention here that the possibility to have, in the compositions of matter mentioned above more than one invention's delivery system is important, as it enables the perfumer to prepare accords and perfumes, capable of releasing the odor tonality of various compounds of formula (IN) used in the preparation of the invention's system, creating thus new tools for their work. Its is also understood here that, unless otherwise indicated or described, any mixture resulting directly from a chemical synthesis, e.g. without an adequate purification, in which the compound of the invention would be involved as a starting, intermediate or end-product could not be considered as a perfuming composition according to the invention. As previously mentioned, an invention's delivery system, in any of its above- mentioned forms, is a useful perfuming ingredient which can be advantageously used in all the fields of modern perfumery, such as fine perfumery or functional perfumery, as it enables a controlled release of odoriferous molecules. Indeed, the invention's delivery system may be advantageously employed in fine or functional perfumery to achieve a more controlled deposition and/or release, of an active perfuming ingredient. For example, perfuming ingredients present as such in washing or perfuming compositions can have little staying-power on a surface and consequently be often eliminated, for example in the rinsing water or upon drying of said surface. This problem can be solved by using an invention's delivery system, for which we have been able to show that it possesses a surprising stability over storage and staying- power or tenacity on surfaces such as textiles. Therefore, the invention's delivery system, owing to a good substantivity, a low volatility and a controlled release of odoriferous molecules, can be incorporated in any application requiring the effect of rapid or prolonged release of an odoriferous component as defined hereinabove and furthermore can impart a fragrance and a freshness to a treated surface which will last well beyond the rinsing and/or drying processes. Suitable surfaces are, in particular, textiles, hard surfaces, hair and skin. Thus, in perfumery, one of the major advantages of the invention resides in the fact that the invention's delivery system imparts an intense fragrance to the treated surface, produced by an odoriferous enone, which would not be detected on said surface over a sufficiently long period if the α,β-unsaturated carbonyl derivative of formula (IN) had been used as such, i.e. without a precursor. Therefore, another object of the present invention is a perfumed article comprising: i) as perfuming ingredient at least one invention's delivery system as defined above, provided that P is a group of formula (H) as defined above; and ii) a consumer product base; is also an object of the present invention. For the sake of clarity, it has to be mentioned that, by "consumer product base" we mean here a consumer product, i.e. a consumable product such as a detergent or a perfume. In other words, a perfumed article according to the invention comprises the functional formulation, as well as optionally additional benefit agents, corresponding to a consumer product, e.g. a detergent or an air freshener, and an olfactive effective amount of at least one invention's delivery system. The nature and type of the constituents of the consumer product do not warrant a more detailed description here, which in any case would not be exhaustive, the skilled person being able to select them on the basis of its general knowledge and according to the nature and the desired effect of said product. Examples of suitable perfumed articles include solid or liquid detergents and fabric softeners as well as all the other articles of common use in perfumery, namely perfumes, colognes or after-shave lotions, perfumed soaps, shower or bath salts, mousses, oils or gels, hygiene products or hair care products such as shampoos, body-care products, deodorants or antiperspirants, air fresheners and also cosmetic preparations. As detergents there are intended applications such as detergent compositions or cleaning products for washing up or for cleaning various surfaces, e.g. intended for textile, dish or hard-surface treatment, whether they are intended for domestic or industrial use. Other perfumed articles are fabric refreshers, ironing waters, papers, wipes or bleaches. Preferred articles are perfumes, fabric detergents or softener bases. Typical examples of fabric detergents or softener compositions into which the compounds of the invention can be incorporated are described in WO 97/34986 or in US patents 4,137,180 and 5,236,615 or EP 799 885. Other typical detergent and softening compositions which can be used are described in works such as Ullman's Encyclopedia of Industrial Chemistry, vol. A8, pages 315 - 448 (1987) and vol. A25, pages 747 - 817 (1994); Flick, Advanced Cleaning Product Formulations, Noye Publication, Park Ridge, New Jersey (1989); Showell, in Surfactant Science Series, vol. 71: Powdered Detergents, Marcel Dekker, New York (1988); Proceedings of the World Conference on Detergents (4th, 1998, Montreux, Switzerland), AOCS print. Some of the above-mentioned articles may represent an aggressive medium for the invention's delivery system, so that it may be necessary to protect the latter from premature decomposition, for example by encapsulation. The proportions in which the delivery system according, wherein P is derived from an active perfuming ingredient, to the invention can be incorporated into the various aforementioned articles or compositions vary within a wide range of values. These values are dependent upon the nature of the article or product to be perfumed and on the desired olfactory effect as well as on the nature of the co-ingredients in a given composition when the invention's delivery system is mixed with perfurning coingredients, solvents or additives commonly used in the art. For example, typical concentrations are in the order of 0.1% to 5% by weight, or even up to 10% of invention's delivery system based on the weight of the composition into which it is incorporated. Concentrations lower than these, such as of the order of 0.01% to 1% by weight, can be used when the present delivery systems are applied directly in the perfuming of the various consumer products mentioned hereinabove. A further object of the present invention concerns the use of a delivery system as defined above, wherein P is derived from an active therapeutical steroid, as a pharmaceutical agent. Furthermore, the present invention concerns also a pharmaceutical composition comprising a delivery system according to the second main embodiment of the invention. The invention will now be described in further detail by way of the following examples, wherein the abbreviations have the usual meaning in the art, the temperatures are indicated in degrees centigrade (°C) ; the ]MMR spectral data were recorded in CDC13 1 1 ^
(if not stated otherwise) with a 360 or 400 MHz machine for H and C, the chemical displacement δ are indicated in ppm with respect to the TMS as standard, the coupling constants J are expressed in Hz.
Example 1
Synthesis of compounds of formula (HI)
a) Synthesis of (+)-3-{[3-(triethoxysilyl)propyl]thio}-l-(2, 6, 6-trimethyl-2-cyclohexen-l- yl)-l-butanone To a stirred solution of α-damascone (9.60 g, 50.0 mmol) and DBU (1.52 g, 10.0 mmol) in THF (40 ml), was rapidly added, at 25-40°, 3-mercaptopropyl-triethoxysilane (95% pure from ABCR, 12.52 g, 50.0 mmol). After 2h, the reaction mixture was poured onto cold 5% aqueous HC1 solution and extracted twice with Et O. The organic phases were washed (H O, saturated aqueous NaHCO3 solution and saturated aqueous NaCl solution), dried (Na2SO ), filtered and concentrated. The crude extract was dried 1 hour at 65-70°/l Pa to give 21.20 g of thioether (pale yellow oil, diastereomeric mixture ca. 55:45, yield = 98.5%). 1H-NMR (major diastereomer): 0.74 (t, J=8.5, 2H), 0.9 (s, 3H), 0.92 (s, 3H), 1.22 (t, J=7.0, 9H), 1.28 (t, J=7.0, 3H), 1.6 (s, 3H), 1.71 (m, 4H), 2.15 (m, 2H), 2.52- 2.94 (m, 5H), 2.28 (m, 1H), 3.81 (q, J=7.0, 6H), 5.59 (s, 1H) 13C-NMR (major diastereomer): 211.0 (s), 130.0 (s), 123.7 (d), 63.7 (d), 58.4 (t), 53.2 (t), 34.4 (d), 33.9 (t), 32.5 (s), 30.8 (t), 28.0 (q), 27.8 (q),.23.5 (q), 23.4 (t), 21.6 (q), 22.6 (t), 18.3 (q), 10.1 (f)
b) Synthesis of (+P4-{[3-trimethoxysilyl)propylJthioP4-(2, 6, 6-trimethyl-Pcyclohexen~l- yiP2-butanone To a well-stirred mixture of β-ionone (10.00 g, 52.1 mmol) and DBU (79.20 mg, 0.52 mmol) was rapidly added at 25-30° (cooling bath: 15°) 3-mercaptopropyl- trimethoxysilane (10.21 g from ABCR, 52.1 mmol). After 72h, the reaction mixture was poured onto a cold stirred 5% aqueous HC1 solution and extracted twice with Et2O. The organic phases were washed (H2O, saturated aqueous NaHCO3 solution and saturated aqueous NaCl solution), dried (Na2SO4), filtered and concentrated. The crude extract was dried 1 h at 65-70°/l Pa to gave 18.00 g of thioether (pale yellow oil, containing by 1H-NMR ca. 10% of β-ionone, yield = 80%).
1H-NMR: 0.74 (dt, J=3.5 and 8.5, 2H), 0.94 (s, 3H), 1.15 (s, 3H), 1.35-1.74 (m, 6H), 1.80 (s, 3H), 1.91 (m, 2H), 2.17 (s, 3H), 2.58 (m, 2H), 2.88 (dd, J=3.5 and 18.0, 1H), 3.28 (dd, J=8.0 and 18.0, 1H), 3.56 (s, 9H), 3.99 (dd, J=3.5 and 8.0, 1H)
13C-NMR: 206.6 (s), 139.9 (s); 131.6 (s), 53.2 (t), 50.5 (q), 39.8 (t), 38.1 (d), 37.0 (t), 35.8 (s), 33.7 (t), 30.7 (q), 28.3 (q), 27.9 (q), 22.8 (t), 22.4 (q), 19.3 (t), 8.8 (t)
c) Synthesis of (±P3-{[3-(triethoxysilyl)propyl] aminoPP(2, 6, 6-trimethyl-2-cyclohexen-l- yiPl-butanone α-Damascone (9.60 g; 50 mmol) diluted in Et2O (50 ml) was treated at 20° C with an excess of 3-aminopropyl-triethoxysilane (16.70 g; 75 mmol). The reaction was slightly exothermic, the stirring was continued during 2 days at 20°.
The mixture was concentrated on a vacuum rotator and distilled at 10 Pa with a Vigreux column. The distillation (b.p. 49° -52°) allowed to obtain 17.1 g of the title compound (diastereomeric mixture ca. 60:40, yield = 82%). 1H-NMR (major diastereomer): 0.62-0.66 (m, 2H), 0.90 (s, 3H), 0.92 (s, 3H), 1.05 and 1.08 (d, J = 6 Hz, 3H), 1.11-1.19 ( , 1H), 1.22 (t, J= 7 Hz, 9H), 1.53-1.62 (m, 3H), 1.58 (broad s, 3H), 1.68-1.78 (m, 1H), 1.98-2.16 (m, 2H), 2.47-2.74 ( , 5H), 3.07-3.16 (m, 1H) 3.81 (q, J= 7 HZ, 6H), 5.58 (broad s, 1H). 13C-NMR (major diastereomer): 213.4 (s), 130.0 (s), 123.6 (d), 63.8 (d), 58.3 (t), 53.0 (t), 50.1 (t), 48.8 (d), 32.4 (s), 30.7 (t), 28.1 (q), 27.8 (q), 23.5 (t), 23.5 (q), 22.7 (t), 20.4 (q), 18.3 (q), 8.1(f).
d) Synthesis of (±Ptrans-3-{[3-(triethoxysilyl)proi)yl] aminoPP(2, 6, 6-trimethyl-3- cyclohexen-1-yiPl-butanone
This product was obtained by using the same experimental procedure as described under c) and using (trans)-δ-Damascone as starting compound. The title compound was obtained by distillation (b.p. 10 Pa = 49°-53°) in the form of a mixture of 80/20 mixture of two diastereomers. Yield = 50%. 1H-NMR (major diastereomer): 0.63-0.67 ( , 2H), O.89 (d, J= 7Hz, 3H), 0.94 (s, 3H), 0.97 (s, 3H), 1.07 (d, J= 6 Hz, 3 H), 1.22 (t, J= 7 Hz, 9H), 1.52-1.75 (m, 3H), 1.88-2.01 (m, 1H), 2.23 (d, J= 11 Hz, 1H), 2.41-2.74 (m, 6H), 3.14 (q x t, J= 6 and 6 Hz, 1H), 3.81 (q, J= 7 Hz, 6H), 5.45 (broad d, J= 10 Hz, 1H), 5.50-5.57 (m, 1H). 13C-NMR (major diastereomer): 214.6 (s), 131.9 (d), 124.1 (d), 63.0 (d), 58.4 (t), 55.0 (t), 50.1 (t), 48.5 (d), 41.8 (t), 33.1 (s), 31.6 (d), 29.8 (q), 23.6 (t), 20.7 (q), 20.4 (q), 20.0 (q), 18.3 (q), 8.1 (t).
Example 2
Synthesis of delivery systems according to the invention
a) Preparation of the starting nano particle
315 g tetraethoxysilane (1.27 mol) are mixed with 782 g ethanol (17 mol) (component 1). Separately, 21.23 g of a 35% w/w aqueous solution of ammonia were diluted with 498 g of water (component 2). Component 2 is mixed under vigorous stirring with component 1.
The mixture thus obtained is heated up to 70° C for 8 hours. Afterwards, to the mixture thus obtained were added 9.5 g of Polyoxyethylene sorbitan monooleate (Tween 80, origin ICI), and the mixture was heated under stirring in an autoclave for 4 hours at 230° C, while mamtaining the pressure between 30 and 40 bar. To remove the precipitated powder from the solvent decanting and filter pressing has been used. The so prepared SiO2 powders have been mixed with 12 % w/w, relative to the amount of powder, of the surface modifier Polyoxyethylene sorbitan monooleate (Tween 80), and dipropylene glycol was added. Then, said mixture was treated mechanically using a mortary mill and a 3 roller mill for about 1 to 5 hours (see below). This procedure gives a suspension of nano particles made of silica having a primary particle size comprised between 20 nm and 50 nm, and a specific surface area of about 40 m2/g to 50 m2/g. The dipropylene glycol can be removed, to recover a dry powder, by freeze drying process in a Christ Epsilon 2-60 at -10° C for 24 hours.
Mortary mill: This is a milling machine form by a round Zirconium container. In this pot a round Zirconium pistil is set very close (2 μm) to one side of the pot and is touching the bottom of the container. The container turns with 120 rpm while the pistil is pressed to the bottom of the container with a force of 10 N (1kg). For this kind of treatment, one always needs a solvent with a boiling point beyond 100° C. Water for example will evaporate during the process due to the temperature created by the high shearing forces between container, pistil and suspension.
b) Preparation of the delivery system i) Delivery system having a releasing moiety according to Example la 12.8 g pro-perfume according to example la) are mixed with 107.2 g dipropylene glycol. This mixture is placed into a mortary mill as described above. 131.5 g of freeze-dried nano particle obtained above are slowly added to the solution while the mortary mill is working with 120 rpm. The pressure on the pistil is IO N. The mixture is mixed in the mill for 3 to 5 hours until a highly viscous solution is created. The final product, which is a suspension -of the invention delivery system in dipropylene glycol, has been analyzed using the Zeta sizer, see below. The starting nano particle has no Zero cross over at any pH value while the treated one has a Zero cross over at the pH value of 3. This is a certain indication that the pro-perfume has been bound chemically to the particle, otherwise the zeta potential would only slightly be changed in the measured pH range. The density of the so modified material changed slightly to 2.27 g/cm3, while the surface area decreased to 37.4 m2/g. The particles did not grow during the modification process and still showed a main primary particle size of 20 to 50 nm.
ii) Preparation of the delivery system (pro perfume according to example lb 10.9 g pro-perfume according to example lb) are mixed with 91.3 g dipropylene glycol. This mixture is placed into a mortary mill, container and pistil made of Zirconia. 111.9 g freeze-dried modified Silica powder is slowly added to the solution while the mortary mill is working with 120 rpm. The pressure on the pistil is IO N. The mixture is treated for 3 to 5 hours until a highly viscous solution is created. The final product has been analyzed using a Zeta sizer apparatus, which detects the surface charge of the particle solution dependent on the pH value. The untreated SiO2 has no Zero cross over at any pH value while the treated one has a Zero cross over at the pH value of 3. This is a certain indication that the pro-perfume has been bound chemically to the particle, otherwise the zeta potential would only slightly be changed in the measured pH range. The density and the surface area of this invention's delivery system are similar to those of the one described in example 2.b.i).
iii) Preparation of the delivery system (pro perfume according to example lc 10.9 g pro-perfume according to example lc) are mixed with 91.3 g dipropylene glycol. This mixture is placed into a mortary mill, container and pistil made of Zirconia. 111.9 g freeze-dried modified Silica powder is slowly added to the solution while the mortary mill is working with 120 rpm. Trie pressure on the pistil is IO N. The mixture is treated for 3 to 5 hours until a highly viscous solution is created. The final product has been analyzed using a Zeta sizer apparatus, which detects the surface charge of the particle solution dependent on the pH value. The untreated SiO2 has no Zero cross over at any pH value while the treated one has a Zero cross over at the pH value of 3. This is a certain indication that the pro-perfume has been bound chemically to the particle, otherwise the zeta potential would only slightly be changed in the measured pH range. The density and the surface area of this invention's delivery system are similar to those of the one described in example 2.b.i).
iv) Preparation of the delivery system (pro perfume according to example Id) 10.9 g pro-perfume according to example Id) are mixed with 91.3 g dipropylene glycol. This mixture is placed into a mortary mill, container and pistil made of Zirconia. 111.9 g freeze-dried modified Silica powder is slowly added to the solution while the mortary mill is working with 120 rpm. The pressure on the pistil is IO N. The mixture is treated for 3 to 5 hours until a highly viscous solution is created. The final product has been analyzed using a Zeta sizer apparatus, which detects the surface charge of the particle solution dependent on the pH value. The untreated SiO2 has no Zero cross over at any pH value while the treated one has a Zero cross over at the pH value of 3. This is a certain indication that the pro-perfume has been bound chemically to the particle, otherwise the zeta potential would only slightly be changed in the measured pH range. The density and the surface area of this invention's delivery system are similar to those of the one described in example 2.b.i).
Example 3
A granular fabric detergent base containing an invention delivery system
General procedure
A dispersion of a delivery system according to the invention in DIPGc), respectively an amount of free active compound (see Table 1), were added to 85 g of unperfumed market powder detergent "Via" (Lever Faberge AB, Stockholm, Sweden). After mixing, the perfumed detergent was introduced in the powder compartment of a Miele Novotronic W900-79 CH washing machine. No fabric-softener was used. The machine was loaded with 16 terry towels (28x28cm, about 40g each) and approx. 2.3kg of cotton towels (11 towels, sized 45x85cm). This load was washed at 40°C using the normal cycle program and setting the spin drying adjustment to 900 rpm. After completion of the washing program, the 16 terry towels were line-dried, in a drying room for 24 hours before being evaluated by a 20 people panel. They were then packed loosely in aluminum foil and further evaluated by a 20 people panel after 1, 4 and 7 days. Each panelist was asked to rate the various terry towels tested on an intensity scale of 1 to 7. 1 : no odor, 2 : weak odor, 3 : slightly weak odor, 4 : medium odor, 5 : slightly strong odor, 6 : strong odor, 7 : very strong odor.
As reference, there was used an amount of active compound of formula (IV), i.e. in this case alpha-damascone or alpha-ionone, corresponding to the total amount which could be theoretically released by the invention's delivery system used.
Table 1 : Average value of the intensity rated by panelists over 7 days
Figure imgf000027_0001
a) average of days 1 to 7 b) Theoretical amount of available active compound c) DIP G: dipropylene glycol
As can be seen from Table 1, both delivery systems according to the invention are able to impart to a fabric a significantly more intense odor, than the active compound as such. This effect being present over a long period of time. Example 4
A concentrated fabric softener base containing an invention delivery system
A concentrated fabric softener base was prepared by admixing the following ingredients:
Ingredient Parts by weight Stepantex® VS 90 diester quat 1} 16.5 Calcium chloride 0.2 Deionised water 82.3 100.0
1) origin: Stepan Europe, France
The delivery system according to the invention, in the form of a dispersion in DIPG, was added to 36 g of fabric-softener base above. After a vigorous stirring the mixture was poured in the fabric-softener compartment of a Miele Novotronic W900-79 CH washing machine. No detergent is applied.
Then, 16 small terry towels (28 x 28 cm, about 40 g each) and 2.3 kg of large cotton towels (11 towels of 45 x 85 cm) were washed at 40°C using the short cycle program and setting the spin drying adjustment to 900 rpm. At the end of the wash, the 16 small terry towels were dried in a drying room for 24 hours and then packed loosely in aluminium foil and evaluated by a 20 people panel 3 days and 7 days after the wash. Each panelist was asked to rate the various terry towels tested on an intensity scale of 1 to 7 (1: no odor, 2: weak odor, 3: slightly weak odor, 4: medium odor, 5: slightly strong odor, 6: strong odor, 7: very strong odor). As reference was used a fabric- softener base containing the equimolar amount of free alpha-damascone, alpha-ionone or beta-ionone tested through the same process. The results are summarized in the following table.
Table 2: Average intensity rating of all three evaluations on dry fabric (1, 3 and 7 days after the wash)
Figure imgf000029_0001
Figure imgf000030_0001

Claims

Claims
1. A delivery system comprising an inorganic nano particle moiety covalently bonded by means of n (Si-O)- bonds to at least one releasing moiety of formula
(P-X)m-R-Si(OR >53-)3-n(O→)n (I)
wherein the arrow indicates the location of the bond between said releasing moiety and the nano particle moiety, n representing an integer comprised between 1 to 3, and which a) P represents a group derived from an active perfume ingredient and which is represented by formula (H)
Figure imgf000031_0001
in which the wavy line indicates the location of the bond between said P and X; R1 represents a hydrogen atom, a d to C6 alkoxyl radical or. a Ci to C15 linear or branched or cyclic alkyl, alkenyl or alkadienyl group, optionally substituted by one to four Ci to C alkyl groups; and R2, R3 and R4 represent a hydrogen atom, a C6-8 aromatic ring or a Ci to C15 linear, cyclic or branched alkyl, alkenyl or alkadienyl group, optionally substituted by one to four Ci to C4 alkyl groups; two, or three, of said R1 to R4 being optionally bonded together to form a saturated or unsaturated ring having 6 to 20 carbon atoms and including the carbon atom to which said R1, R2, R3 or R4 groups are bonded, this ring being optionally substituted by one to four Ci to C4 linear or branched alkyl or alkenyl groups; or P represents a group derived from an active therapeutical steroid and is represented by formula
Figure imgf000032_0001
in which the wavy line indicates the location of the bond between said P and X; R10 represents a hydrogen atom or a hydroxy group; A represents a CH2, C=O or CH2OH group; and Rπ represents a hydrogen atom or a C≡CH, CH3CO or HOCH2CO group; b) X represents a functional group selected from the group consisting of the formulae i) to vi):
Figure imgf000032_0002
ii) iii)
Figure imgf000032_0003
iv) v) vi) in which formulae the wavy lines are as defined previously and the bold lines indicate the location of the bond between said X and R, and R6 represents a hydrogen atom or a Ci to C4 alkyl group; c) R represents a linear, branched or cyclic multivalent group (with a m+1 valence) derived from a C1-C15 alkyl or alkylaryl group, said group optionally containing one or two functional groups selected from the group consisting of oxygen and sulfur atoms, CO, COO, CONR6, COS and N(R6)a, R6 being defined as above and a representing 0 or 1, d) R5 represents a linear or branched Ci to C alkyl group; and e) m represents 1, 2 or 3
2. A delivery system according to claim 1, characterised in that the inorganic nano particle moiety is derived from a nano particle made from amorphous or crystalline metals oxides, hydroxides, oxo-hydroxides or mixtures thereof, and the metal is selected from the group consisting of Al, Si, In, Sn, Ca, Ba, Sr, Ti, Zr, Fe, Ag and Zn.
3. A delivery system according to claim 2, characterised in that the inorganic nano particle is made from oxides or hydroxides of Ti, Si, Zr, Al, Fe or mixtures thereof.
4. A delivery system according to any one of claims 1 to 3, characterised in that X is sseelleecctteedd frfroomm tthhee ggrroouupp ccoonnssiisstting of formulae i), ii) and iii), R6 representing a hydrogen atom or a methyl or ethyl group.
5. A delivery system according to any one of claims 1 to 4, characterised in that R represents a linear, branched or cyclic divalent or trivalent group derived from a C -C9 alkyl group optionally containing one or two functional groups selected from the group consisting of oxygen and sulfur atoms, COO, CONR6, andN(R6)a, R6 being defined as in claim 1 and a representing 0 or 1;
R5 represents a methyl, ethyl or propyl group; and m is 1 or 2.
6. A delivery system according to any one of claims 1 to 5, characterised in that P is a group derived from an active perfume α,β-unsaturated ketone, aldehyde or carboxyhc ester having from 8 to 20 carbon atoms.
7. A delivery system according to claim 6, characterised in that P a is group selected from the group consisting of the formulae (P-l) to (P-12)
Figure imgf000034_0001
(P-9) (P-10) (P-li) (P-12)
in the form of any one of their isomers, and wherein the dotted lines represent a single or double bond, R7 represents a methyl or ethyl group, R8 represents a C6 to C linear or branched alkyl, alkenyl or alkadienyl group and R9 represents a hydrogen atom or a methyl group, and the wavy lines have the meaning given in claim 1.
8. A delivery system according to claim 7, characterised in that P is a group selected from the group consisting of the groups of the formulae (P-l) to (P-7).
9. A delivery system according to any one of claims 1 to 5, characterised in that P is a group derived from a therapeutical α,β-unsaturated steroid having from 19 to 26 carbon atoms.
10. A perfuming composition comprising: i) as perfuming ingredient, at least a delivery system as defined in any one of claims 1 to 8, provided that P is a group of formula (H) as in claim 1, 6, 7 or 8; ii) at least one ingredient selected from the group consisting of a perfumery carrier and a perfumery base; and iii) optionally at least one perfumery adjuvant.
11. A perfuming composition comprising: i) as perfuming ingredient, at least a delivery system as defined in any one of claims 1 to 8, provided that P is a group of formula (II) as in claim 1, 6, 7 or 8; ii) water; and iii) optionally at least an anti-floculant ingredient.
12. Use as a perfuming ingredient of a delivery system as defined in any one of claims 1 to 8, provided that P is a group of formula (H) as in claim 1, 6, 7 or 8.
13. A perfumed article comprising: i) as perfuming ingredient, at least a delivery system as defined in any one of claims 1 to 8, provided that P is a group of formula (U) as in claim 1, 6, 7 or 8; ii) a consumer product base.
14. A perfumed article according to claim 13, characterized in that the consumer product base is in the form of a solid or liquid detergent, a fabric softener, a perfume, a cologne, an after-shave lotion, a perfumed soap, a shower or bath salt, mousse, oil or gel, a hygiene product, a hair care product, a shampoo, a body-care product, a deodorant, an antiperspirant, an air freshener, a cosmetic preparation, a fabric refresher, an ironing water, a paper, a wipe or a bleach.
15. A perfumed article according to claim 14, characterized in that the consumer product base is in the form of a fabric softener or a perfume.
16. A delivery system according to claim 9 for a use as a therapeutical agent.
17. A pharmaceutical composition comprising a delivery system according to claim 9.
PCT/IB2004/003539 2003-10-29 2004-10-27 Perfume delivery systems based on inorganic nano particles WO2005041908A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP04769749A EP1687069A1 (en) 2003-10-29 2004-10-27 Perfume delivery systems based on inorganic nano particles
JP2006537471A JP2007511625A (en) 2003-10-29 2004-10-27 Perfume delivery system based on inorganic nanoparticles
US11/416,493 US20060263898A1 (en) 2003-10-29 2006-05-01 Perfume delivery systems based on inorganic nano particles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB0304786 2003-10-29
IBPCT/IB03/04786 2003-10-29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/416,493 Continuation US20060263898A1 (en) 2003-10-29 2006-05-01 Perfume delivery systems based on inorganic nano particles

Publications (1)

Publication Number Publication Date
WO2005041908A1 true WO2005041908A1 (en) 2005-05-12

Family

ID=34531836

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/003539 WO2005041908A1 (en) 2003-10-29 2004-10-27 Perfume delivery systems based on inorganic nano particles

Country Status (3)

Country Link
EP (1) EP1687069A1 (en)
JP (1) JP2007511625A (en)
WO (1) WO2005041908A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008138115A (en) * 2006-11-09 2008-06-19 Kenji Yamamoto Nano particle having odor-stimulating component
DE102007012909A1 (en) 2007-03-19 2008-09-25 Momentive Performance Materials Gmbh Fragrance-modified, reactive polyorganosiloxanes
WO2014202591A1 (en) * 2013-06-19 2014-12-24 Firmenich Sa Polysiloxane conjugates as fragrance delivery systems
US8927026B2 (en) 2011-04-07 2015-01-06 The Procter & Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
US9162085B2 (en) 2011-04-07 2015-10-20 The Procter & Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105566852A (en) * 2014-11-05 2016-05-11 住友电木株式会社 Resin composition for thermally conductive sheet, base material-attached resin layer, thermally conductive sheet, and semiconductor device
US9902920B2 (en) * 2014-12-10 2018-02-27 Firmenich Sa Polysiloxanes as fragrance delivery systems in fine perfumery
EP3468500A4 (en) * 2016-06-09 2020-03-04 Blinkbio Inc. Silanol based therapeutic payloads

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005815A1 (en) * 1991-09-16 1993-04-01 Syngenix Limited Synthetic transfection vectors
EP0535942A2 (en) * 1991-10-02 1993-04-07 Unilever Plc Perfume particles
DE19841147A1 (en) * 1998-09-09 2000-03-16 Henkel Kgaa Kiselsäureester
DE10021165A1 (en) * 2000-04-29 2001-11-08 Henkel Kgaa Active substance release system

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005815A1 (en) * 1991-09-16 1993-04-01 Syngenix Limited Synthetic transfection vectors
EP0535942A2 (en) * 1991-10-02 1993-04-07 Unilever Plc Perfume particles
DE19841147A1 (en) * 1998-09-09 2000-03-16 Henkel Kgaa Kiselsäureester
DE10021165A1 (en) * 2000-04-29 2001-11-08 Henkel Kgaa Active substance release system

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008138115A (en) * 2006-11-09 2008-06-19 Kenji Yamamoto Nano particle having odor-stimulating component
DE102007012909A1 (en) 2007-03-19 2008-09-25 Momentive Performance Materials Gmbh Fragrance-modified, reactive polyorganosiloxanes
US9186642B2 (en) 2010-04-28 2015-11-17 The Procter & Gamble Company Delivery particle
US11096875B2 (en) 2010-04-28 2021-08-24 The Procter & Gamble Company Delivery particle
US9993793B2 (en) 2010-04-28 2018-06-12 The Procter & Gamble Company Delivery particles
US8927026B2 (en) 2011-04-07 2015-01-06 The Procter & Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
US9162085B2 (en) 2011-04-07 2015-10-20 The Procter & Gamble Company Personal cleansing compositions with increased deposition of polyacrylate microcapsules
US9561169B2 (en) 2011-04-07 2017-02-07 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
US8980292B2 (en) 2011-04-07 2015-03-17 The Procter & Gamble Company Conditioner compositions with increased deposition of polyacrylate microcapsules
US10143632B2 (en) 2011-04-07 2018-12-04 The Procter And Gamble Company Shampoo compositions with increased deposition of polyacrylate microcapsules
CN105324416A (en) * 2013-06-19 2016-02-10 弗门尼舍有限公司 Polysiloxane conjugates as fragrance delivery systems
US9765282B2 (en) 2013-06-19 2017-09-19 Firmenich Sa Polysiloxane conjugates as fragrance delivery systems
WO2014202591A1 (en) * 2013-06-19 2014-12-24 Firmenich Sa Polysiloxane conjugates as fragrance delivery systems

Also Published As

Publication number Publication date
EP1687069A1 (en) 2006-08-09
JP2007511625A (en) 2007-05-10

Similar Documents

Publication Publication Date Title
CN110167667B (en) Microcapsules
CN107530269B (en) Stable dispersions
US20060263898A1 (en) Perfume delivery systems based on inorganic nano particles
DE102005043188A1 (en) Consumable products with changing odor images
JP2000501450A (en) Fragrance delivery system
US9765282B2 (en) Polysiloxane conjugates as fragrance delivery systems
DE102005043189A1 (en) Consumable products with fragrance variety
EP2038391A1 (en) Washing, cleaning and care products
CN107074713B (en) Phenyl-based compounds substituted with aldehyde moieties and their use in perfumery
EP3259339B1 (en) Poly(aspartic acid) derived copolymers for a controlled release of perfuming ingredients
EP1687069A1 (en) Perfume delivery systems based on inorganic nano particles
CN107074732B (en) Improvements in or relating to organic compounds
CN112840011B (en) Consumer product and delivery system using organoleptic compounds
EP4094827A1 (en) Aqueous dispersion of microcapsules, and uses thereof
WO2004105713A1 (en) Compounds for a controlled release of active molecules
JP2023553367A (en) Synergistic perfume composition
EP1904541B1 (en) Amphiphilic co-polymer conjugates for a controlled release of active molecules
JP6562910B2 (en) Bicycloaldehyde as perfuming ingredient
JP5897119B2 (en) Penta / hexamethyl-3,4,5,8-tetrahydro-1 (2H) -naphthalenone derivatives having aromatic notes
JP4191637B2 (en) Fragrance composition, flavoring product, use of esters having C2-C4-unsaturated groups and such compounds
CN107074714B (en) Improvements in or relating to organic compounds
JPH032920B2 (en)
CN110520404B (en) Alpha alkylation of aldehydes with polycyclic olefins
WO2024096037A1 (en) Fragrance composition and consumer product
JP2004210958A (en) Perfume composition and method for improving or increasing aromaticity of aromatic product

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004769749

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006537471

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 11416493

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2004769749

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 11416493

Country of ref document: US